Abeona Therapeutics
Abeona Therapeutics28
About
Pricing
View pricing page ↗
What does Abeona Therapeutics do?
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing cell and gene therapies for serious and life-threatening rare diseases. Their lead product, ZEVASKYN (prademagene zamikeracel), is an autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosa (RDEB). The company also has a pipeline of AAV-based gene therapies for ophthalmic and other rare genetic disorders.
What is Abeona Therapeutics's revenue?
StartupHub estimates Abeona Therapeutics's annual revenue at $9.1M (range $5.4M to $36.8M, 62% confidence), based on comparable companies in the sector.
Where is Abeona Therapeutics headquartered?
Abeona Therapeutics is headquartered in Cleveland, United States.
When was Abeona Therapeutics founded?
Abeona Therapeutics was founded in 1974.
What industry does Abeona Therapeutics operate in?
Abeona Therapeutics operates in Biotech, Gene Therapy, Rare Diseases.
How many employees does Abeona Therapeutics have?
Abeona Therapeutics has approximately 229 people on record.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
Discover innovative AI therapeutics at fibrotherapeutics.ai, enhancing patient care and advancing health technology.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.